华绿生物
(300970)
| 流通市值：21.80亿 | | | 总市值：28.18亿 |
| 流通股本：1.24亿 | | | 总股本：1.60亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 693,881,412.3 | 414,243,699.16 | 1,291,890,340.95 | 867,669,135 |
| 营业收入 | 693,881,412.3 | 414,243,699.16 | 1,291,890,340.95 | 867,669,135 |
| 二、营业总成本 | 636,029,193.71 | 297,997,767.92 | 1,179,931,454.88 | 858,235,706.04 |
| 营业成本 | 586,745,722.56 | 281,135,029.26 | 1,083,907,393.68 | 790,102,924.63 |
| 税金及附加 | 526,999.56 | 227,482.41 | 791,377.64 | 522,799.82 |
| 销售费用 | 7,034,670.81 | 2,887,448.59 | 10,473,593.71 | 6,634,235.19 |
| 管理费用 | 36,288,538.85 | 14,041,849.88 | 58,830,903.55 | 44,033,748.63 |
| 研发费用 | 8,974,781.48 | 3,646,290.12 | 17,368,705.95 | 11,369,406.35 |
| 财务费用 | -3,541,519.55 | -3,940,332.34 | 8,559,480.35 | 5,572,591.42 |
| 其中:利息费用 | 10,541,376.9 | - | 15,970,456.41 | 11,302,821.01 |
| 其中:利息收入 | 14,099,890.21 | - | 7,442,420.28 | 5,753,565.86 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 248,986.31 | - | - | 0 |
| 资产处置收益 | 102,977.56 | 101,081.15 | -2,147,494.3 | -438,905.09 |
| 资产减值损失(新) | -8,450,277.54 | 107,757.18 | 151,765.13 | -699,213.55 |
| 信用减值损失(新) | 339,191.49 | - | -80,456.62 | 143,613.37 |
| 其他收益 | 5,523,166.48 | 2,788,328.11 | 13,977,493.26 | 8,504,609.2 |
| 四、营业利润 | 55,616,262.89 | 119,243,097.68 | 123,860,193.54 | 16,943,532.89 |
| 加:营业外收入 | 379,191.69 | 153,767.54 | 577,208.43 | 373,579.1 |
| 减:营业外支出 | 236,824.97 | 125,150.13 | 5,132,322.96 | 464,686.3 |
| 五、利润总额 | 55,758,629.61 | 119,271,715.09 | 119,305,079.01 | 16,852,425.69 |
| 减:所得税费用 | -40,366.08 | - | 49,311.04 | 8,555.2 |
| 六、净利润 | 55,798,995.69 | 119,271,715.09 | 119,255,767.97 | 16,843,870.49 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | - | - | 119,255,767.97 | - |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 46,096,252.7 | 109,891,608.16 | 110,268,302.23 | 16,333,517.64 |
| 少数股东损益 | 9,702,742.99 | 9,380,106.93 | 8,987,465.74 | 510,352.85 |
| 扣除非经常损益后的净利润 | 44,558,669.31 | 109,567,475.54 | 112,747,362.5 | 15,529,540.25 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.29 | 0.91 | 0.93 | 0.14 |
| (二)稀释每股收益 | 0.29 | 0.91 | 0.93 | 0.14 |
| 九、综合收益总额 | 55,798,995.69 | 119,271,715.09 | 119,255,767.97 | 16,843,870.49 |
| 归属于母公司股东的综合收益总额 | 46,096,252.7 | 109,891,608.16 | 110,268,302.23 | 16,333,517.64 |
| 归属于少数股东的综合收益总额 | 9,702,742.99 | 9,380,106.93 | 8,987,465.74 | 510,352.85 |
| 公告日期 | 2026-08-20 | 2026-04-22 | 2026-04-22 | 2025-10-24 |
| 审计意见(境内) | | | 标准无保留意见 | |